The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119947806 11994780 6 F 2015 20160912 20160203 20160913 EXP AR-PFIZER INC-2016001921 PFIZER 70.00 YR F Y 0.00000 20160913 CN AR AR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119947806 11994780 1 PS SUTENT SUNITINIB MALATE 1 50 MG, CYCLIC (4/2) Y 420AB 21938 50 MG CAPSULE, HARD
119947806 11994780 2 SS SUTENT SUNITINIB MALATE 1 UNK Y 991PC 21938 CAPSULE, HARD
119947806 11994780 3 SS SUTENT SUNITINIB MALATE 1 UNK Y 68CPC 21938 CAPSULE, HARD
119947806 11994780 4 SS SUTENT SUNITINIB MALATE 1 37.5 MG, CYCLIC Y 680AD 21938 37.5 MG CAPSULE, HARD
119947806 11994780 5 SS SUTENT SUNITINIB MALATE 1 UNK Y 21938 CAPSULE, HARD
119947806 11994780 6 SS SUTENT SUNITINIB MALATE 1 UNK Y 21938 CAPSULE, HARD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119947806 11994780 1 Metastatic renal cell carcinoma

Outcome of event

Event ID CASEID OUTC COD
119947806 11994780 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119947806 11994780 Amnesia
119947806 11994780 Anxiety
119947806 11994780 Blood potassium decreased
119947806 11994780 Blood pressure fluctuation
119947806 11994780 Blood pressure increased
119947806 11994780 Blood sodium decreased
119947806 11994780 Burning sensation
119947806 11994780 Condition aggravated
119947806 11994780 Coordination abnormal
119947806 11994780 Decreased immune responsiveness
119947806 11994780 Diabetes mellitus
119947806 11994780 Disease progression
119947806 11994780 Erythema
119947806 11994780 Loss of consciousness
119947806 11994780 Lung infection
119947806 11994780 Malaise
119947806 11994780 Metastatic renal cell carcinoma
119947806 11994780 Pain
119947806 11994780 Pruritus
119947806 11994780 Rash
119947806 11994780 Skin exfoliation
119947806 11994780 Skin lesion
119947806 11994780 Skin sensitisation
119947806 11994780 Stomatitis
119947806 11994780 Syncope
119947806 11994780 Time perception altered
119947806 11994780 Urinary tract infection
119947806 11994780 Visual impairment
119947806 11994780 Yellow skin

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119947806 11994780 1 20151204 20160105 0
119947806 11994780 5 20160318 0
119947806 11994780 6 20160530 0